Ubtech Robotics is moving from AI humanoid concepts to commercial hardware, showing strong momentum in the first half of the year. Management has reaffirmed optimistic revenue guidance for the full year, targeting 10,000 unit deliveries in 2026 and 30,000–50,000 cumulative units by 2027. The company plans to expand its product lineup with new industrial, commercial, and consumer robots. Analysts value the stock at $20 per share, expecting about 48% upside, based on a 10x–12x EV/Revenue multiple, supported by Ubtech's diverse product portfolio and AI capabilities. Key risks include execution challenges, pricing competition, and possible geopolitical restrictions on Nvidia GPU components.
Ultragenyx Pharmaceutical Inc. awarded 44,409 restricted stock units to 15 newly hired non-executive officers under its Employment Inducement Plan. The grants, approved by the compensation committee, vest over four years with 25% vesting annually, co...
Nyxoah has announced an extraordinary general meeting of shareholders set for July 9, 2026, at its headquarters in Belgium. The meeting will discuss renewing the authorization for the board to increase the company's capital over the next five years, ...
Eupraxia Pharmaceuticals held its Annual General Meeting on June 18, 2026, where shareholders elected all seven board nominees proposed by management with strong majority votes. Additionally, KPMG LLP was reappointed as the company's auditor for the ...
Cate & Chloe is discounting its Bianca 18k Gold-Plated Crystal Hoop Earrings to $19.98 from $86 during Amazon Prime Day 2026, running June 23-26. This 77% markdown aligns with growing consumer demand for affordable luxury jewelry, with earrings price...
Regency Silver Corp. announced strong assay results from nine drill holes totaling 6,234 meters at its Dios Padre Project in Sonora, Mexico, confirming high-grade gold, copper, and silver mineralization and expansion of the breccia system. The most s...
